|
Market Closed -
London S.E.
16:35:14 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 12,824.00 GBX | -1.20% |
|
+3.04% | -7.01% |
| 07:00pm | Takeda to seek Japan approval for gastric cancer drug next year | RE |
| 06:16pm | AstraZeneca's stomach cancer drug extends overall survival, late-stage trial data finds | RE |
Chart calendar AstraZeneca PLC
Upcoming events on AstraZeneca PLC
| 30/10/2026 | Earnings release - Q3 2026 | 07:00 |
| 30/10/2026 | Earnings presentation | 14:30 |
Past events on AstraZeneca PLC
| 27/07/2026 | Earnings release - Q2 2026 | 07:00 |
| 27/07/2026 | Earnings presentation | 11:45 |
| 06/07/2026 | Information meeting | 14:30 |
| 30/04/2026 | Information meeting | |
| 29/04/2026 | Earnings release - Q1 2026 | 07:00 |
| 29/04/2026 | Earnings presentation | 14:30 |
| 09/04/2026 | Annual General Meeting | 15:30 |
| 09/04/2026 | Présentation aux Actionnaires / Analystes | 14:30 |
| 10/02/2026 | Earnings release - Q4 2025 | |
| 10/02/2026 | Earnings presentation | 11:45 |
| 18/11/2025 | Information meeting | |
| 06/11/2025 | Earnings release - Q3 2025 | 07:00 |
| 06/11/2025 | Earnings presentation | 13:00 |
| 03/11/2025 | Présentation aux Actionnaires / Analystes | 14:30 |
| 03/11/2025 | Extraordinary General Meeting |
Past dividends on AstraZeneca PLC
| 06/08/2026 | Ex-dividend date - 0.795 GBX | 05:00 |
| 19/02/2026 | Ex-dividend date - 1.595 GBX | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 45 811 45 716 0.21% | 54 073 53 340 1.37% | 58 739 58 651 0.15% | 63 323 | 67 370 | 71 483 |
|
EBITDA Million USD | Released Forecast Spread | 13 580 15 477 -12.26% | 16 691 16 909 -1.29% | 19 476 19 668 -0.98% | 22 150 | 24 458 | 27 030 |
|
EBIT Million USD | Released Forecast Spread | 14 534 15 036 -3.34% | 16 928 17 034 -0.63% | 18 478 18 819 -1.81% | 21 071 | 23 304 | 25 629 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 899 9 269 -25.57% | 8 691 10 318 -15.77% | 12 402 12 888 -3.77% | 14 705 | 17 606 | 19 786 |
|
Net income Million USD | Released Forecast Spread | 5 961 6 597 -9.64% | 7 035 8 172 -13.91% | 10 225 10 070 1.54% | 11 747 | 13 676 | 15 346 |
|
EPS USD | Released Forecast Spread | 3,81 4,34 -12.22% | 4,50 5,33 -15.6% | 6,54 6,34 3.11% | 7,65 | 8,93 | 10,1 |
| Announcement Date | 08/02/24 | 06/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14 891 14 181 5.01% | 13 588 13 741 -1.11% | 14 457 14 095 2.57% | 15 191 14 769 2.86% | 15 503 15 371 0.86% | 15 288 14 931 2.39% | 15 384 15 417 -0.21% | 15 995 | 16 665 | 15 972 | 16 312 | 17 107 | 17 602 |
|
EBITDA Million USD | Released Forecast Spread | 4 373 5 435 -19.54% | 4 958 5 324 -6.87% | 4 897 4 284 14.31% | 5 132 4 936 3.97% | 4 489 6 081 -26.18% | 5 612 5 811 -3.42% | 5 092 7 348 -30.71% | 7 472 | 8 092 | ||||
|
EBIT Million USD | Released Forecast Spread | 4 199 4 300 -2.34% | 4 803 4 583 4.81% | 4 584 4 495 1.99% | 4 993 4 753 5.05% | 4 098 4 383 -6.51% | 5 352 5 170 3.53% | 5 158 5 101 1.13% | 5 374 | 5 209 | 5 357 | 5 309 | 6 034 | 5 571 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 666 2 825 -41.03% | 3 127 2 874 8.8% | 3 244 3 487 -6.97% | 3 914 3 623 8.03% | 2 799 3 743 -25.21% | 3 951 | 3 818 | ||||||
|
Net income Million USD | Released Forecast Spread | 1 500 3 284 -54.32% | 2 916 2 458 18.63% | 2 450 2 497 -1.87% | 2 533 2 782 -8.94% | 2 326 2 801 -16.95% | 3 080 3 104 -0.76% | 2 507 3 087 -18.8% | 3 237 | 3 708 | ||||
|
EPS USD | Released Forecast Spread | 0,96 2,11 -54.44% | 1,88 1,57 19.47% | 1,57 1,66 -5.38% | 1,62 1,78 -9.18% | 1,49 1,80 -17.29% | 1,97 2,01 -2.19% | 1,61 2,01 -20.02% | 2,13 | 2,52 | ||||
| Announcement Date | 06/02/25 | 29/04/25 | 29/07/25 | 06/11/25 | 10/02/26 | 29/04/26 | 27/07/26 | - | - | - | - | - | - |
| 26/10/2026 |  | Information meeting | 14:00 |
| 26/10/2026 | | Earnings release - Q2 2027 | |
| 26/10/2026 | | Board of Directors Meeting | |
| 26/10/2026 | | Earnings presentation | 12:30 |
| 26/10/2026 | | Earnings presentation | 07:00 |
| 26/10/2026 | | Earnings release - Q3 2026 | |
| 26/10/2026 | | Earnings presentation | 08:00 |
| 26/10/2026 | | Extraordinary General Meeting | 17:00 |
| 26/10/2026 | | Earnings presentation | 11:00 |
| 26/10/2026 | | Board of Directors Meeting |
Past sector events for AstraZeneca PLC
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 | |
| 24/10/2026 | | Earnings release - Q3 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- Calendar AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
